Candida auris: estrategias y retos para prevenir un brote

Alejandra Zuluaga-Rodríguez, .

Palabras clave: Candida auris


La descarga de datos todavía no está disponible.

Referencias bibliográficas

1. Meis JF, Chowdhary A. Candida auris: A global fungal public health threat. Lancet Infect Dis. 2018;18:1298-9.
2. Morales-López SE, Parra-Giraldo CM, Ceballos-Garzón A, Martínez HP, Rodríguez GJ, Álvarez-Moreno CA, et al. Invasive infections with multidrug-resistant yeast Candida auris, Colombia. Emerg Infect Dis. 2017;23:162-4.
3. Parra-Giraldo CM, Valderrama SL, Cortes-Fraile G, Garzón JR, Ariza BE, Morio F, et al. First report of sporadic cases of Candida auris in Colombia. Int J Infect Dis. 2018;69:63-7.
4. Escandón P, Chow NA, Caceres DH, Gade L, Berkow EL, Armstrong P, et al. Molecular epidemiology of Candida auris in Colombia reveals a highly related, countrywide colonization with regional patterns in amphotericin B resistance. Clin Infect Dis. 2019;68:15-21.
5. Escandón P, Cáceres DH, Espinosa-Bode A, Rivera S, Armstrong P, Vallabhaneni S, et al. Notes from the Field: Surveillance for Candida auris — Colombia, September 2016–May 2017. MMWR Morb Mortal Wkly Rep. 2018;67:459-60.
6. Jeffery-Smith A, Taori SK, Schelenz S, Jeffery K, Johnson EM, Borman A, et al. Candida auris: a review of the literature. Clin Microbiol Rev. 2017;31.
7. Sarma S, Kumar N, Sharma S, Govil D, Ali T, Mehta Y, et al. Candidemia caused by amphotericin B and fluconazole resistant Candida auris. Indian J Med Microbiol. 2013;31:90-1.
8. Caceres DH, Forsberg K, Welsh RM, Sexton DJ, Lockhart SR, Jackson BR, et al. Candida auris: a review of recommendations for detection and control in healthcare settings. J Fungi (Basel). 2019;5.
9. Centers for Disease Control and Prevention. Recommendations for identification of Candida auris. Fecha de consulta: 8 de febrero de 2020. Disponible en:
10. Ambaraghassi G, Dufresne PJ, Dufresne SF, Vallieres E, Munoz JF, Cuomo CA, et al. Identification of Candida auris using the updated 8.01 VITEK2 yeast identification system: A multilaboratory evaluation study. J Clin Microbiol. 2019;57.
11. Clinical and Laboratory Standards Institute. Interpretive criteria for identification of bacteria and fungi by DNA target sequencing: approved guideline. MM18-A. Wayne, PA: CLSI; 2008.
12. Lockhart SR, Berkow EL, Chow N, Welsh RM. Candida auris for the clinical microbiology laboratory: Not your grandfather’s Candida species. Clin Microbiol Newsl. 2017;39:99-103.
13. Lockhart SR, Jackson BR, Vallabhaneni S, Ostrosky-Zeichner L, Pappas PG, Chiller T. Thinking beyond the common Candida species: need for species-level identification of Candida due to the emergence of multidrug-resistant Candida auris. J Clin Microbiol. 2017;55:3324-7.
14. Sexton DJ, Kordalewska M, Bentz ML, Welsh RM, Perlin DS, Litvintseva AP. Direct detection of emergent fungal pathogen Candida auris in clinical skin swabs by SYBR Green-based quantitative PCR assay. J Clin Microbiol. 2018;56.
15. Kathuria S, Singh PK, Sharma C, Prakash A, Masih A, Kumar A, et al. Multidrug-resistant Candida auris misidentified as Candida haemulonii: Characterization by matrix-assisted laser desorption ionization-time of flight mass spectrometry and DNA sequencing and its antifungal susceptibility profile variability by Vitek 2, CL. J Clin Microbiol. 2015;53:1823-30.
16. Kordalewska M, Zhao Y, Lockhart SR, Chowdhary A, Berrio I, Perlin DS. Rapid and accurate molecular identification of the emerging multidrug-resistant pathogen Candida auris. J Clin Microbiol. 2017;55:2445-52.
17. Centers for Disease Control and Prevention. Antifungal susceptibility testing and interpretation. Fecha de consulta: 13 de febrero de 2020. Disponible en:
18. Schelenz S, Hagen F, Rhodes JL, Abdolrasouli A, Chowdhary A, Hall A, et al. First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob Resist Infect Control. 2016;5:35.
19. Vallabhaneni S, Kallen A, Tsay S, Chow N, Welsh R, Kerins J, et al. Investigation of the first seven reported cases of Candida auris, a globally emerging invasive, multidrugresistant fungus - United States, May 2013-August 2016. MMWR Morb Mortal Wkly Rep. 2016;65:1234-7.
20. Welsh RM, Bentz ML, Shams A, Houston H, Lyons A, Rose LJ, et al. Survival, persistence, and isolation of the emerging multidrug-resistant pathogenic yeast Candida auris on a plastic health care surface. J Clin Microbiol. 2017;55:2996-3005.
21. Centers for Disease Control and Prevention. Recommendations for infection prevention and control for Candida auris. 2018. Fecha de consulta: 13 de febrero de 2020. Disponible en:
22. Newman E. Bleach wipes kill Candida auris. 2019. Fecha de consulta: 12 de febrero de 2020. Disponible en:
23. Dimond VJ. EPA approves diversey claim that oxiver 1 is effective against C. auris. 2019. Fecha de consulta: 8 de febrero de 2020. Disponible en:
24. Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62:e1-e50.
Cómo citar
Zuluaga-Rodríguez A. Candida auris: estrategias y retos para prevenir un brote. biomedica [Internet]. 1 de marzo de 2020 [citado 1 de marzo de 2021];40(1):5-10. Disponible en: